Gilbert Varela, M.D INC.

Gilbert Varela, M.D INC. was paid $242K by Medicaid between Feb 2020 and Aug 2021, across 47 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 26% of everything it billed.

Compared with peers

Next to other Health Maintenance Organization providers in California

Rank by total paid#51 of 151

Median peer was paid$59K

This provider vs. median4.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	5,895	$122K
2021	5,390	$119K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	26%	649	440	$63K
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	15%	344	273	$35K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	12%	300	172	$29K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	4.4%	347	338	$11K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	4.4%	347	338	$11K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	3.8%	378	238	$9K
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	3.7%	137	124	$9K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	3.4%	382	380	$8K
80061	Lipid panel	3.4%	711	707	$8K
84443	Thyroid stimulating hormone (TSH)	3.2%	591	584	$8K
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	2.9%	175	144	$7K
99334		2.6%	1,126	1,028	$6K

35 more codes

80053	Comprehensive metabolic panel	2.3%	681	$5K
83036	Hemoglobin; glycosylated (A1C)	2.1%	662	$5K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.1%	846	$5K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	1.8%	214	$4K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	1.6%	229	$4K
99201		1.3%	53	$3K
71045	Radiologic examination, chest; single view	<1%	306	$2K
99335		<1%	119	$2K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	<1%	215	$1K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	88	$960.00
86592		<1%	244	$852.44
86480		<1%	24	$770.56
81001		<1%	194	$462.59
82043		<1%	86	$406.40
87086	Culture, bacterial; quantitative colony count, urine	<1%	53	$377.16
93000		<1%	13	$373.10
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	16	$352.50
84439		<1%	40	$298.60
92552		<1%	18	$173.10
86803		<1%	13	$163.41
83655		<1%	14	$148.82
82570		<1%	24	$107.87
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	43	$92.70
94760		<1%	12	$67.08
90658		<1%	32	$9.00
90685		0%	18	$0.00
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	0%	48	$0.00
85018		0%	125	$0.00
99213	Doctor's office visit, returning patient (routine)	0%	840	$0.00
82962		0%	92	$0.00
99214	Doctor's office visit, returning patient (more involved)	0%	242	$0.00
36415	Collection of venous blood by venipuncture	0%	115	$0.00
97802		0%	28	$0.00
90686		0%	39	$0.00
99441		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialVARELA, GILBERT (PRESIDEN & CEO)

Parent organizationGILBERT VARELA M.D, INC